Stem Cell Therapy for Perianal Crohn’s Disease

Aim. To compare the effectiveness of the effect of combination therapy (local and systemic administration) with bone marrow mesenchymal stromal cells (MSC), anticlitokine therapy with infliximab (IFX), and antibiotic (AB)/immunosuppressive (IS) therapy on the frequency of healing of simple perianal...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: O V Knyazev, N A Fadeeva, A V Kagramanova, N I Belyakov, N V Orlova, A A Lishchinskaya, A G Konoplyannikov, A I Parfenov
Format: Artigo
Jezik:Russo
Izdano: "Consilium Medicum" Publishing house 2018-03-01
Serija:Терапевтический архив
Teme:
crohn's disease
infliximab
fistula form
mesenchymal stromal cells
stem cell therapy
Online pristup:https://ter-arkhiv.ru/0040-3660/article/viewFile/32743/pdf
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items